FEP vs. MM/PBSA vs. Docking for Compound Prioritization

01Scope and Rationale

If your team has more proposed analogs than it can synthesize, the useful question is which calculation can discriminate among those particular choices. A library of unrelated scaffolds, a close analog series with measured affinities, and a series with uncertain poses need different approaches. Creative Biostructure's binding free-energy calculation services provide a route to discuss FEP/TI and endpoint analysis against your actual inputs. Bring the chemical decision and reference data to the discussion before selecting a method solely by its name.

Ask which decision the calculation must support

Compound prioritization can mean selecting diverse molecules for testing, ranking substitutions within a series, comparing target and off-target binding, or investigating a structural hypothesis. Those are different tasks. No single computational method is automatically best for all of them, and a more expensive calculation does not repair an unsupported receptor model simply by producing a more detailed number.

Docking proposes molecular arrangements and scores them using an approximate recognition model. Endpoint approaches such as MM/PBSA or MM/GBSA evaluate contributions from sampled configurations using molecular mechanics and an implicit-solvent treatment. Alchemical free-energy methods compare defined thermodynamic states through a sampling protocol. The distinction matters because the outputs, assumptions, and appropriate checks are not identical.

For a broad library with limited experimental evidence, a useful first outcome may be a chemically diverse test set. For close analogs with a supported binding mode, relative free-energy calculations may address a specific substitution question. For a flexible or poorly characterized site, the immediate priority may instead be resolving the structural hypothesis. State that decision explicitly before choosing software or a computational budget.

Keep scores, estimates, and measurements distinct

A docking score is not an experimentally measured dissociation constant. An endpoint energy estimate should not automatically be interpreted as an absolute binding free energy. An alchemical result depends on the states, standard-state treatment where relevant, force field, and sampling used. Report the method and interpretation alongside every numerical output rather than presenting a mixed column of values as one common potency scale.

For a relative binding calculation, define the direction of the comparison. A reported difference between compounds B and A should identify which sign favors which molecule. Relative changes can be related to equilibrium affinity only under compatible thermodynamic definitions. An activity endpoint such as IC50 can depend on assay conditions and mechanism; it should not be silently substituted for a binding constant during calibration or validation.

Use evidence to decide the level of investment

Creative Biostructure's binding free-energy calculation services provide a route to discussing FEP, TI, and endpoint analyses. Scope should follow the series, target, input quality, and intended decision. Avoid fixed statements that every early series requires one method and every final series requires another; the appropriateness of the calculation depends on the actual scientific problem.

Compare the methods on their own terms

Docking often prioritizes plausible recognition arrangements using a simplified scoring framework. Its useful output may be a set of structural hypotheses and a diversified experimental proposal. An endpoint calculation samples selected configurations and estimates contributions under an implicit-solvent model. Its value may lie in a comparative analysis or a hypothesis about interactions. An alchemical calculation defines a thermodynamic comparison and requires appropriate sampling of the specified states. These distinctions should remain clear in the final report.

For a closely related series, a relative calculation can be organized around transformations that connect the proposed compounds. The network should support comparisons important to the chemical decision and expose useful consistency checks where feasible. A technically convenient network can still be scientifically unhelpful if it avoids the substitutions the team actually needs to evaluate. Discuss difficult transformations during scoping instead of excluding them silently from a favorable performance summary.

Absolute binding work addresses a different setup problem and may require additional choices about state definition and restraints. It should not be presented as merely relative FEP with a different label. The interpretation of the reported quantity must match the protocol. If several methods are combined, explain whether they are successive filters, alternative hypotheses, or complementary analyses rather than blending their numerical outputs into an unexplained consensus.

Identify structural changes that can disrupt a simple comparison

A substitution may alter more than a local contact. It can change the preferred ionization state, displace or stabilize water, favor a different pose, or require a protein rearrangement. Those possibilities can affect the validity or sampling demands of the proposed calculation. Flag them before interpreting an unexpected result as a minor numerical error. The appropriate response may involve another structural hypothesis or an experiment rather than simply a longer run.

Illustrative planning example, not a company case study: a team proposes two analogs expected to retain the same pose, but one introduces a charged group near a partly buried region. The key question is whether the prepared molecular states and environment represent a meaningful comparison. If those assumptions remain unresolved, a precise relative number would not remove the uncertainty. A limited experimental or structural assessment may be the more informative next step.

Another series may have good structural support yet very small measured potency differences. In that situation, both experimental and computational uncertainties matter. Define whether the intended prediction can actually change the synthesis choice. It may be more useful to select compounds that test a larger mechanistic difference or improve another property, rather than insisting on a confident affinity ranking among nearly indistinguishable candidates.

The resulting method choice should therefore include a statement of applicability: which chemical series, states, and decisions were assessed, which cases were excluded, and why. That statement makes a successful project interpretable without implying that the same protocol has been validated for unrelated targets, scaffolds, or biological endpoints.

02Step-by-Step Computational Method Selection

1. 1

   Define the chemical comparison and experimental endpoint

   List the compounds, proposed substitutions, and decision to be made. Identify whether the project concerns affinity, selectivity, or another property. Record stereochemistry, relevant ionization and tautomer states, and known experimental conditions. Review whether the available data describe the same target state, construct, and measurement type.

   Specify how the predictions will be used. A qualitative explanation, a ranked experimental set, and a numerical comparison before synthesis require different expectations. Decide what degree of uncertainty would change the action. If plausible differences are smaller than the method's uncertainty for the system, report that limitation rather than forcing an artificial ranking.

2. 2

   Establish the receptor and binding-mode hypothesis

   Review experimental or predicted coordinates, local site evidence, missing regions, protonation, cofactors, and relevant molecular state. Examine whether ligands are expected to retain a common binding mode. Changes in loop conformation, buried water, charge state, or coordination can complicate an apparently simple substitution.

   Molecular docking can support pose exploration or initial prioritization when appropriately scoped. Use available structural and experimental references to assess the hypothesis. Retain alternatives that could lead to different predictions, and avoid treating the top-ranked pose as established fact solely because a subsequent calculation needs one starting structure.
3. 3

   Use docking for a suitable recognition question

   Docking can be useful for exploring how candidates might occupy a site and for organizing a broader test set. Inspect chemical plausibility, receptor-state sensitivity, and diversity alongside numerical rank. Review strain and interaction patterns rather than assuming that every additional favorable contact represents a reliable gain in affinity.

   When reference data exist, use relevant controls to examine protocol behavior. A pose-reproduction check and prospective enrichment answer different questions. Define what each test establishes and retain failures. Additional scoring functions can provide another computational perspective, but they do not constitute experimental validation simply because their outputs agree.

4. 4

   Evaluate whether endpoint analysis adds useful information

   MM/PBSA and related endpoint approaches can investigate sampled interaction and solvation contributions under specified assumptions. Consider trajectory preparation, snapshot selection, consistency of the molecular states, and the treatment of terms that are difficult to estimate. Explain whether the intended output is a comparative ranking, a qualitative interaction analysis, or another limited interpretation.

   Per-residue decomposition can help generate hypotheses, but its components are model-dependent and should not be treated as directly measured residue contributions. Do not interpret an attractive decomposition plot as a recipe that guarantees improved chemistry. Ask whether the analysis distinguishes alternatives that docking alone could not resolve and whether the conclusion is stable to reasonable analytical choices.

5. 5

   Plan an alchemical calculation when the comparison supports it

   For relative FEP or TI, specify the endpoints, mapping, transformations, and relevant molecular states. Consider whether changes in charge, scaffold, binding mode, or local environment create additional complexity. The transformation network and reference compounds should be chosen to support useful comparisons rather than only the easiest pairings.

   For absolute binding calculations, define the bound state, restraints, and standard-state conventions as appropriate to the implementation. Discuss the additional setup and sampling demands. Neither relative nor absolute calculations should be described as automatically reliable for every protein–ligand system. A feasibility review should identify where structural uncertainty or difficult transitions are likely to dominate the result.

6. 6

   Inspect sampling, diagnostics, and experimental agreement

   Review convergence behavior, overlap between relevant states, independent repeats where appropriate, and consistency checks such as cycle closure for a suitable network. These diagnostics can reveal problems, but passing them does not remove every systematic error. Distinguish statistical uncertainty from uncertainty due to the model, starting structure, or omitted molecular behavior.

   Molecular dynamics analysis can support investigation of structural behavior relevant to a calculation. Where experimental comparisons are available, retain a clear distinction between calibration data and prospective tests. Do not report a retrospective fit as proof of general predictive performance for new scaffolds, targets, or assay conditions.
7. 7

   Translate the output into an experimentally testable choice

   Combine the predictions with synthetic accessibility, solubility questions, assay feasibility, and the project's objectives. A compound with a promising affinity estimate may still be unhelpful if it cannot test the key structural hypothesis or carries an unresolved practical limitation. Explain which proposed analogs are expected to provide the most information.

   Use SAR analysis to connect measured changes with structural explanations where appropriate. Include compounds that could falsify the preferred hypothesis, not only examples expected to agree. Record which results would trigger model revision, additional structural work, or a stop decision. The calculation should guide learning rather than replace the next measurement.

03Common Pitfalls and How to Avoid Them

• Claiming a universal accuracy or ranking guarantee

  Performance depends on the system, data, preparation, and protocol. A published benchmark is evidence about its tested conditions, not a guarantee for every client project. Agree on applicable diagnostics and validation rather than advertising a fixed error range without context.

• Treating simulation length as sufficient validation

  Longer sampling may help some questions but does not prove that all relevant states were explored. Inspect the behavior required by the comparison and retain alternative structural explanations. A stable trajectory can remain confined to an incorrect starting hypothesis.

• Comparing incompatible quantities

  Scores, endpoint energies, relative free energies, and assay potencies should not be pooled without explaining their meaning. State units, sign conventions, references, and experimental conditions. Apparent disagreement can reflect different definitions rather than a direct test of the same physical quantity.

• Using calculation to explain every observed outlier

  Review experimental uncertainty, compound material, assay context, and mechanism as well as structural models. Avoid revising the computational explanation until it matches every retrospective observation by construction. Preserve an independent test of the revised hypothesis where feasible.

04Deliverables

An informative computational report connects the numerical work to the original decision. Agree on which systems, repeats, diagnostics, trajectories, and analyses are included. A completed job or a small reported error bar does not by itself establish that the intended comparison was valid.

• Defined systems and assumptions

  Provide structures, compound identities, molecular states, preparation records, and an explanation of the comparison. For alchemical work, specify the relevant endpoints and transformation plan. Keep alternative poses or important unresolved assumptions visible in the interpretation.

• Results with meaningful uncertainty

  Report calculated quantities, units, reference direction, and the uncertainty supported by the analysis. Distinguish numerical precision from predictive accuracy. Explain when compounds cannot be ranked confidently instead of filling every position with a definitive order.

• Diagnostics and reproducibility information

  Include agreed convergence checks, overlap or consistency assessments where relevant, analysis settings, and appropriate files for reuse. Record exceptions and unsuccessful calculations. A summary should not conceal the systems excluded because they were difficult to interpret.

• A prioritized experimental proposal

  Explain which compounds or structural questions should be tested next and why. Include practical chemical considerations and the evidence that would change the model. Separate an affinity hypothesis from claims about selectivity, exposure, cellular activity, or overall developability.

05Integrated Research Solutions

Choose a service scope around your next chemistry round

Creative Biostructure offers molecular docking, molecular dynamics, binding free-energy calculations, and SAR analysis. For outsourcing, begin with the molecules you need to compare and the action that will follow the result. You may want a first shortlist from a library, a comparison of proposed substitutions, or an explanation of an activity change within an existing series. Each objective places different demands on receptor preparation, binding-mode evidence, and comparable experimental measurements.

For a new scaffold set, discuss whether pose assessment and initial prioritization should precede a more detailed calculation. For a supported analog series, ask whether FEP/TI is suitable for the planned transformations. Endpoint analysis may have a role where its assumptions fit the question. A proposal should explain the method choice and the limiting uncertainties rather than assigning every project the same sequence of computational tools.

Prepare structures, chemistry, and reference measurements

Supply the target and construct, receptor structures or models, ligand coordinates if available, and machine-readable compound structures with stereochemistry defined. Include measured affinity or activity data together with assay conditions, rather than a potency column without context. Mark proposed compounds that have not yet been synthesized and identify changes in charge, scaffold, covalent chemistry, or binding mode that may complicate comparisons.

State the number of compounds, the decision deadline, and whether the aim is affinity ranking, selectivity comparison, or interpretation of existing SAR. If the structural starting point is uncertain, say so in the brief. These details let the technical discussion separate preparation and feasibility work from production calculations, and identify a limited initial comparison when a full-series calculation would rest on unresolved assumptions.

Ask for decision-ready outputs and an explicit expansion plan

For an initial engagement, agree on the systems, comparisons, reference compounds, analysis outputs, and review criteria. Request uncertainty estimates and diagnostic information appropriate to the method, along with a clear explanation of how the results support prioritization. Specify which prepared inputs, result tables, and reproducibility information are required by your internal computational or medicinal chemistry team.

Discuss how the work will be reviewed before expanding to additional analogs. If predictions cannot distinguish candidates, the useful output may be a recommendation for a discriminating experiment or a revised structural hypothesis rather than a forced ranking. The quotation should identify preparation, calculation, and interpretation work, and clarify whether subsequent experimental testing is included. This makes the computational budget accountable to a concrete design decision without presenting predicted affinity as measured cellular activity.

06Frequently Asked Questions

07References

1. 1.
   Mey ASJS, Allen BK, Bruce McDonald HE, et al. Best Practices for Alchemical Free Energy Calculations. Living Journal of Computational Molecular Science. 2020.
2. 2.
   Lee TS, Allen BK, Giese TJ, et al. Alchemical Binding Free Energy Calculations in AMBER20: Advances and Best Practices for Drug Discovery. Journal of Chemical Information and Modeling. 2020.
3. 3.
   Knight JL, Clark AJ, Wang J, et al. Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study. Nature Communications. 2025.